Brought to you by 
Cytyc buys Adiana for $60mm cash, plus earn-out
02 Apr 2007
Executive Summary
Cytyc (women's health and cancer diagnostics) has agreed to acquire Adiana, a private company that has created a non-incisional alternative to a permanent form of contraception-tubal ligation. Cytyc will pay $60mm in cash up front, plus a milestone payment for FDA approval and an earn-out based on four years of sales; altogether the transaction will not exceed $215mm.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com